NABOTA® (JEUVEAU®) 200u

Nabota 200U is a Botulinum Toxin Type A injection used to smooth facial wrinkles, address muscle-related conditions, and reduce excessive sweating (hyperhidrosis). Trusted worldwide for high purity and effectiveness, Nabota provides natural-looking results for frown lines, forehead wrinkles, crow’s feet, and more.

Key Benefits

• Dual-Vial Flexibility: Choose 100u vials for targeted treatments or 200u vials for practice efficiency and reduced waste in high-volume settings.
• High Purity & Precision: 900kDa formulation allows precise muscle modulation and predictable, natural-looking outcomes.
• FDA-Approved Consistency: Proven safety and reliability for glabellar lines.
• Strong Value Proposition: Offers a balance of performance, purity, and cost for both growing practices and maintaining treatment quality.

Target Areas for Treatment

• FDA-Approved Primary Indication:
  • Moderate to Severe Glabellar Lines (frown lines between the eyebrows)
• Common Off-Label Aesthetic Uses:
  • Forehead Lines (Frontalis muscle)
  • Lateral Canthal Lines ("Crow's Feet")
  • Brow Shaping & Lift
  • Bunny Lines (nasal bridge)
  • Perioral Lines (ultra-conservative micro-dosing)
  • Mentalis Muscle (chin dimpling)
  • Masseter Reduction (jaw slimming)
  • Platysmal Bands (neck contouring)

Important Tips for Medical Practitioners

• Follow Nabota-Specific Dosing: Units are not directly interchangeable with other neuromodulators. Start with Nabota-specific guidelines and adjust based on patient response and muscle mass.
• Optimize Reconstitution for Precision: 100u vials typically diluted with 1–2.5 mL preservative-free saline; 200u vials with proportional volumes (e.g., 2–5 mL) for precision and even distribution.
• Leverage its Localized Profile: Focused diffusion allows precise sculpting, but broader areas like the forehead may need multiple injection points.
• Storage & Handling: Store unopened vials refrigerated (2°C–8°C). Use reconstituted vials within 24 hours; plan treatments to utilize 200u vials efficiently.
• Patient Selection & Consultation: Perform dynamic facial analysis. Discuss FDA approval, purity, onset (2–5 days), and duration (3–4 months) with patients.

Disclaimer: This information is for professional educational use only. Safe and effective administration of Nabota requires medical training, licensure, and expertise in facial anatomy. Alura Medical Supply verifies active medical licenses for all orders.